pfizer limited

Live MatureMegaHigh

pfizer limited Company Information

Share PFIZER LIMITED

Company Number

00526209

Shareholders

pfizer luxco holdings sarl

Group Structure

View All

Industry

Other research and experimental development on natural sciences and engineering

 +1

Registered Address

pfizer limited, ramsgate road, sandwich, kent, CT13 9NJ

pfizer limited Estimated Valuation

£2.1b

Pomanda estimates the enterprise value of PFIZER LIMITED at £2.1b based on a Turnover of £1.2b and 1.8x industry multiple (adjusted for size and gross margin).

pfizer limited Estimated Valuation

£967.7m

Pomanda estimates the enterprise value of PFIZER LIMITED at £967.7m based on an EBITDA of £89m and a 10.87x industry multiple (adjusted for size and gross margin).

pfizer limited Estimated Valuation

£1.4b

Pomanda estimates the enterprise value of PFIZER LIMITED at £1.4b based on Net Assets of £711.1m and 1.92x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Pfizer Limited Overview

Pfizer Limited is a live company located in kent, CT13 9NJ with a Companies House number of 00526209. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in November 1953, it's largest shareholder is pfizer luxco holdings sarl with a 100% stake. Pfizer Limited is a mature, mega sized company, Pomanda has estimated its turnover at £1.2b with high growth in recent years.

View Sample
View Sample
View Sample

Pfizer Limited Health Check

Pomanda's financial health check has awarded Pfizer Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 8 measures and has 1 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

8 Strong

positive_score

2 Regular

positive_score

1 Weak

size

Size

annual sales of £1.2b, make it larger than the average company (£14.3m)

£1.2b - Pfizer Limited

£14.3m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 28%, show it is growing at a faster rate (5.4%)

28% - Pfizer Limited

5.4% - Industry AVG

production

Production

with a gross margin of 37%, this company has a comparable cost of product (37%)

37% - Pfizer Limited

37% - Industry AVG

profitability

Profitability

an operating margin of 6.5% make it more profitable than the average company (4.3%)

6.5% - Pfizer Limited

4.3% - Industry AVG

employees

Employees

with 1244 employees, this is above the industry average (40)

1244 - Pfizer Limited

40 - Industry AVG

paystructure

Pay Structure

on an average salary of £80.2k, the company has an equivalent pay structure (£69.9k)

£80.2k - Pfizer Limited

£69.9k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £931k, this is more efficient (£395.4k)

£931k - Pfizer Limited

£395.4k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 28 days, this is earlier than average (56 days)

28 days - Pfizer Limited

56 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 24 days, this is quicker than average (37 days)

24 days - Pfizer Limited

37 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 56 days, this is less than average (90 days)

56 days - Pfizer Limited

90 days - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Pfizer Limited

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 45.3%, this is a lower level of debt than the average (50.5%)

45.3% - Pfizer Limited

50.5% - Industry AVG

PFIZER LIMITED financials

EXPORTms excel logo

Pfizer Limited's latest turnover from November 2023 is £1.2 billion and the company has net assets of £711.1 million. According to their latest financial statements, Pfizer Limited has 1,244 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Nov 2023Nov 2022Nov 2021Nov 2020Nov 2019Nov 2018Nov 2017Nov 2016Nov 2015Nov 2014Nov 2013Nov 2012Nov 2011Nov 2010Nov 2009
Turnover1,158,133,0003,082,999,0002,122,498,000552,679,000605,569,000641,922,000850,303,0001,048,456,0001,149,864,0001,256,543,0001,359,501,0001,576,731,0001,831,528,0001,594,929,0001,444,245,000
Other Income Or Grants
Cost Of Sales730,232,4761,928,137,8561,350,375,459345,949,062378,410,290396,000,398530,762,933651,316,221734,010,101810,057,159866,306,3031,117,917,0001,383,080,0001,051,321,7471,155,396,000
Gross Profit427,900,5241,154,861,144772,122,541206,729,938227,158,710245,921,602319,540,067397,139,779415,853,899446,485,841493,194,697458,814,000448,448,000543,607,253288,849,000
Admin Expenses352,160,5241,025,939,144678,264,541114,567,938196,320,710226,879,602101,803,067195,061,779503,654,899516,533,841483,878,697517,860,000508,376,000589,870,253283,727,000
Operating Profit75,740,000128,922,00093,858,00092,162,00030,838,00019,042,000217,737,000202,078,000-87,801,000-70,048,0009,316,000-59,046,000-59,928,000-46,263,0005,122,000
Interest Payable453,000371,00031,000428,00084,000170,000253,000864,0001,314,0001,367,0001,244,0003,051,000100,050,000104,019,00086,464,000
Interest Receivable34,706,00019,938,000901,0002,254,0003,058,0001,784,000536,000309,0002,00062,000174,0001,324,000118,604,000110,273,000100,520,000
Pre-Tax Profit168,453,000169,936,000113,888,000130,457,000112,658,000339,299,000217,729,000214,460,000-69,545,00055,268,00084,736,00097,935,000-759,700,00027,082,00020,175,000
Tax-35,409,000-33,486,000-95,964,000-15,244,000-14,083,000-96,668,000-40,711,000-42,392,0002,234,000-15,197,000-2,536,000-5,408,000184,769,00020,975,00022,434,000
Profit After Tax133,044,000136,450,00017,924,000115,213,00098,575,000242,631,000177,018,000172,068,000-67,311,00040,071,00082,200,00092,527,000-574,931,00048,057,00042,609,000
Dividends Paid550,000,000190,000,000
Retained Profit133,044,000-413,550,00017,924,000115,213,00098,575,00052,631,000177,018,000172,068,000-67,311,00040,071,00082,200,00092,527,000-574,931,00048,057,00042,609,000
Employee Costs99,771,00088,984,000100,833,000101,505,000138,711,000249,589,000222,809,000254,106,000249,837,000239,846,000254,840,000282,877,000385,564,000376,975,000344,461,000
Number Of Employees1,2441,1751,2121,2581,3652,2532,2572,2222,1892,2162,3573,2804,1344,5124,337
EBITDA*89,013,000139,884,000104,860,000103,733,00042,963,00041,983,000238,745,000231,751,000-67,530,000-44,727,00034,946,000-17,655,00028,689,00040,524,00098,264,000

* Earnings Before Interest, Tax, Depreciation and Amortisation

Nov 2023Nov 2022Nov 2021Nov 2020Nov 2019Nov 2018Nov 2017Nov 2016Nov 2015Nov 2014Nov 2013Nov 2012Nov 2011Nov 2010Nov 2009
Tangible Assets42,864,00045,309,00048,149,00048,090,00051,814,00053,027,00085,933,00089,309,00089,632,00089,629,00088,330,00071,103,000103,117,000790,244,000832,912,000
Intangible Assets5,911,0006,921,00014,334,00020,603,00033,900,00041,197,00074,662,00069,970,00088,537,00099,604,000160,879,000220,042,000276,433,000273,709,000285,326,000
Investments & Other173,590,000291,934,000717,070,000183,772,000183,530,000182,680,000271,477,000241,728,000324,226,000298,741,000323,081,000434,086,000495,137,000430,378,00081,891,000
Debtors (Due After 1 year)
Total Fixed Assets222,365,000344,164,000779,553,000252,465,000269,244,000276,904,000432,072,000401,007,000502,395,000487,974,000572,290,000725,231,000874,687,0001,494,331,0001,200,129,000
Stock & work in progress113,411,000102,562,000114,546,000135,580,000149,324,000121,652,000110,429,000146,466,000176,352,000168,424,000182,904,000187,393,000224,045,000193,625,000137,123,000
Trade Debtors91,157,000630,743,000323,150,00094,180,000235,851,000286,692,000285,742,000290,130,000279,011,000313,303,000294,611,000273,771,000361,605,000334,414,000260,562,000
Group Debtors837,501,0001,278,815,0001,339,018,0001,137,881,000944,964,000860,554,0001,010,922,000933,395,000782,168,000659,405,000679,038,000550,895,0002,975,995,0003,024,521,0001,672,323,000
Misc Debtors35,989,00038,462,00041,753,00072,388,00074,748,00052,769,00039,865,00067,126,000113,170,000133,464,000141,094,000165,511,000203,435,00059,787,00049,023,000
Cash193,000236,0002,000205,00014,467,000
misc current assets475,000729,0001,582,000
total current assets1,078,058,0002,050,582,0001,818,467,0001,440,029,0001,404,887,0001,322,142,0001,447,687,0001,438,699,0001,350,701,0001,274,789,0001,297,883,0001,177,572,0003,765,285,0003,612,347,0002,133,498,000
total assets1,300,423,0002,394,746,0002,598,020,0001,692,494,0001,674,131,0001,599,046,0001,879,759,0001,839,706,0001,853,096,0001,762,763,0001,870,173,0001,902,803,0004,639,972,0005,106,678,0003,333,627,000
Bank overdraft8,00011,00044,000
Bank loan
Trade Creditors 49,789,00043,905,00029,292,00046,617,00051,096,00092,218,000125,848,000145,377,000121,773,00089,213,00067,878,00084,490,00087,125,00093,547,00096,515,000
Group/Directors Accounts299,727,0001,092,366,000703,635,000286,389,000315,027,000248,750,000794,779,000832,791,000973,487,000952,430,0001,079,616,0001,343,130,0003,930,125,0003,706,818,0002,332,713,000
other short term finances1,162,000
hp & lease commitments
other current liabilities194,353,000550,954,000383,276,000283,260,000176,386,000219,313,000145,691,000188,398,000128,492,000111,518,000125,266,000131,269,000257,733,000248,358,000207,359,000
total current liabilities543,877,0001,687,225,0001,116,203,000616,266,000542,509,000560,292,0001,066,318,0001,166,610,0001,223,752,0001,153,161,0001,272,760,0001,558,889,0004,274,983,0004,049,885,0002,636,587,000
loans167,153,000198,108,000136,465,00040,212,00037,820,000
hp & lease commitments
Accruals and Deferred Income460,00015,630,00017,075,000857,000992,0001,230,0001,936,0003,865,0009,846,0009,894,000
other liabilities
provisions21,652,00027,372,000115,416,00021,189,000185,352,000186,377,00024,969,00091,653,00081,035,0001,800,00013,722,00021,061,00041,771,000113,772,000148,576,000
total long term liabilities45,491,00066,564,000163,691,00054,815,000235,567,000216,897,00035,559,000216,518,000248,188,000199,908,000150,187,00045,460,00051,665,000177,490,000340,776,000
total liabilities589,368,0001,753,789,0001,279,894,000671,081,000778,076,000777,189,0001,101,877,0001,383,128,0001,471,940,0001,353,069,0001,422,947,0001,604,349,0004,326,648,0004,227,375,0002,977,363,000
net assets711,055,000640,957,0001,318,126,0001,021,413,000896,055,000821,857,000777,882,000456,578,000381,156,000409,694,000447,226,000298,454,000313,324,000879,303,000356,264,000
total shareholders funds711,055,000640,957,0001,318,126,0001,021,413,000896,055,000821,857,000777,882,000456,578,000381,156,000409,694,000447,226,000298,454,000313,324,000879,303,000356,264,000
Nov 2023Nov 2022Nov 2021Nov 2020Nov 2019Nov 2018Nov 2017Nov 2016Nov 2015Nov 2014Nov 2013Nov 2012Nov 2011Nov 2010Nov 2009
Operating Activities
Operating Profit75,740,000128,922,00093,858,00092,162,00030,838,00019,042,000217,737,000202,078,000-87,801,000-70,048,0009,316,000-59,046,000-59,928,000-46,263,0005,122,000
Depreciation4,297,0004,693,0004,733,0004,274,0004,828,00011,282,0009,904,00011,106,0009,204,0009,690,00010,800,00012,682,00066,938,00065,628,00071,954,000
Amortisation8,976,0006,269,0006,269,0007,297,0007,297,00011,659,00011,104,00018,567,00011,067,00015,631,00014,830,00028,709,00021,679,00021,159,00021,188,000
Tax-35,409,000-33,486,000-95,964,000-15,244,000-14,083,000-96,668,000-40,711,000-42,392,0002,234,000-15,197,000-2,536,000-5,408,000184,769,00020,975,00022,434,000
Stock10,849,000-11,984,000-21,034,000-13,744,00027,672,00011,223,000-36,037,000-29,886,0007,928,000-14,480,000-4,489,000-36,652,00030,420,00056,502,000137,123,000
Debtors-983,373,000244,099,000399,472,00048,886,00055,548,000-136,514,00045,878,000116,302,00068,177,000-8,571,000124,566,000-2,550,858,000122,313,0001,436,814,0001,981,908,000
Creditors5,884,00014,613,000-17,325,000-4,479,000-41,122,000-33,630,000-19,529,00023,604,00032,560,00021,335,000-16,612,000-2,635,000-6,422,000-2,968,00096,515,000
Accruals and Deferred Income-371,771,000166,233,000116,234,000106,739,000-43,165,00072,916,000-44,636,00063,771,00016,974,000-13,748,000-15,849,000-126,512,00019,269,00040,999,000207,359,000
Deferred Taxes & Provisions-5,720,000-88,044,00094,227,000-164,163,000-1,025,000161,408,000-66,684,00010,618,00079,235,000-11,922,000-7,339,000-20,710,000-72,001,000-34,804,000148,576,000
Cash flow from operations654,521,000-32,915,000-176,406,000-8,556,000-139,652,000271,300,00057,344,000200,936,000-12,632,000-41,208,000-127,467,0002,414,590,0001,571,000-1,428,590,000-1,545,883,000
Investing Activities
capital expenditure-9,818,000-709,000-4,792,0005,450,000-3,615,00043,430,000-22,324,000-10,783,000-9,207,00034,655,00016,306,00047,014,000595,786,000-32,502,000-1,211,380,000
Change in Investments-118,344,000-425,136,000533,298,000242,000850,000-88,797,00029,749,000-82,498,00025,485,000-24,340,000-111,005,000-61,051,00064,759,000348,487,00081,891,000
cash flow from investments108,526,000424,427,000-538,090,0005,208,000-4,465,000132,227,000-52,073,00071,715,000-34,692,00058,995,000127,311,000108,065,000531,027,000-380,989,000-1,293,271,000
Financing Activities
Bank loans
Group/Directors Accounts-792,639,000388,731,000417,246,000-28,638,00066,277,000-546,029,000-38,012,000-140,696,00021,057,000-127,186,000-263,514,000-2,586,995,000223,307,0001,374,105,0002,332,713,000
Other Short Term Loans -1,162,0001,162,000
Long term loans-167,153,000-30,955,00061,643,000136,465,000-40,212,0002,392,00037,820,000
Hire Purchase and Lease Commitments
other long term liabilities
share issue-62,946,000-263,619,000278,789,00010,145,000-24,377,000-8,656,000144,286,000-96,646,00038,773,000-77,603,00066,572,000-107,397,0008,952,000474,982,000313,655,000
interest34,253,00019,567,000870,0001,826,0002,974,0001,614,000283,000-555,000-1,312,000-1,305,000-1,070,000-1,727,00018,554,0006,254,00014,056,000
cash flow from financing-821,332,000144,679,000696,905,000-16,667,00044,874,000-553,071,000106,557,000-405,050,00027,563,000-144,451,000-61,547,000-2,696,119,000209,439,0001,858,895,0002,698,244,000
cash and cash equivalents
cash-193,000-43,000234,000-203,000205,000-14,467,00014,467,000
overdraft8,000-11,00011,000-44,00044,000
change in cash-8,00011,000-11,00044,000-44,000-193,000-43,000234,000-203,000205,000-14,467,00014,467,000

pfizer limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for pfizer limited. Get real-time insights into pfizer limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Pfizer Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for pfizer limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mega companies, companies in CT13 area or any other competitors across 12 key performance metrics.

pfizer limited Ownership

PFIZER LIMITED Shareholders

pfizer luxco holdings sarl 100%

pfizer limited directors

Pfizer Limited currently has 6 directors. The longest serving directors include Dr Berkeley Phillips (Oct 2012) and Mr Edwin Pearson (Jan 2017).

officercountryagestartendrole
Dr Berkeley PhillipsEngland55 years Oct 2012- Director
Mr Edwin PearsonEngland51 years Jan 2017- Director
Mr Roger SmithEngland58 years Oct 2019- Director
Mr David HightonEngland56 years Jun 2022- Director
Mrs Sarah Sainsbury53 years May 2024- Director
Dr John McGinley48 years Oct 2024- Director

P&L

November 2023

turnover

1.2b

-62%

operating profit

75.7m

-41%

gross margin

37%

-1.37%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

November 2023

net assets

711.1m

+0.11%

total assets

1.3b

-0.46%

cash

0

0%

net assets

Total assets minus all liabilities

Similar Companies

Similar companies unavailable for this selection

pfizer limited company details

company number

00526209

Type

Private limited with Share Capital

industry

72190 - Other research and experimental development on natural sciences and engineering

46460 - Wholesale of pharmaceutical goods

incorporation date

November 1953

age

72

incorporated

UK

ultimate parent company

PFIZER INC

accounts

Full Accounts

last accounts submitted

November 2023

previous names

N/A

accountant

-

auditor

KPMG LLP

address

pfizer limited, ramsgate road, sandwich, kent, CT13 9NJ

Bank

-

Legal Advisor

-

pfizer limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to pfizer limited.

pfizer limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for PFIZER LIMITED. This can take several minutes, an email will notify you when this has completed.

pfizer limited Companies House Filings - See Documents

datedescriptionview/download